The Safety and Tolerability of CSL112, a Reconstituted, Infusible, Human APOA-I, After Acute Myocardial Infarction - The APOA-I Event Reduction in Ischemic Syndromes I (AEGIS-I) Trial Gibson, C., Korjian, S., Tricoci, P., Daaboul, Y., Alexander, J. H., Steg, P. G., Lincoff, A. M., Kastelein, J. J., Mehran, R., D'Andrea, D., Merkely, B., Zarebinski, M., Ophius, T., Harrington, R. A. LIPPINCOTT WILLIAMS & WILKINS. 2016: E706

View details for Web of Science ID 000390560100011